Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Amr HanbaliAhmed KotbRiad El FakihFeras AlfraihNahla ShihataWalid RasheedSyed Osman AhmedMarwan ShaheenSaud AlhayliAli AlahmariAhmad AlotaibiAlfadel AlshaibaniAbdulwahab AlbabtainMansour AlfayezMaha HassanFahad AlsharifNaeem ChaudhriFahad AlmoharebHazzaa AlzahraniMahmoud AljurfPublished in: International journal of hematologic oncology (2023)
Our single-center experience real-world data in treating T-ALL/LBL-AYA patients with pediatric-inspired protocol demonstrates encouraging results of high survival rate and excellent tolerability for patients aged 18-55 years.
Keyphrases
- acute lymphoblastic leukemia
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- free survival
- prognostic factors
- open label
- clinical trial
- allogeneic hematopoietic stem cell transplantation
- patient reported outcomes
- big data
- young adults
- machine learning
- study protocol
- deep learning
- double blind